Structural characteristics of the M2 protein of influenza a viruses: Evidence that it forms a tetrameric channe (original) (raw)

Abstract

The evidence presented shows that the M2 protein of influenza A viruses exists in infected cells as a homotetramer composed of two disulfide-linked dimers held together by noncovalent interactions. The amphiphilic nature of the transmembrane α-helical domain is consistent with the protein forming a transmembrane channel with which amantadine, the specific anti-influenza A drug, interacts. Together these features provide a structural basis for the hypothesis that M2 has a proton translocation function capable of regulating the pH of vesicles of the trans-Golgi network, a role important in promoting the correct maturation of the hemagglutinin glycoprotein.

References

  1. Bean W.J., Threlkeld S.C., Webster R.G. Biologic potential of amantadine-resistant influenza A virus in an avian model. J. Infect. Dis. 1989;159:1050–1056. doi: 10.1093/infdis/159.6.1050. [DOI] [PubMed] [Google Scholar]
  2. Belshe R.B., Hall-Smith M., Hall C.B., Betts R., Hay A.J. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol. 1988;62:1508–1512. doi: 10.1128/jvi.62.5.1508-1512.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belshe R.B., Hay A.J. Drug resistance and the mechanisms of action on influenza A virus. J. Respir. Dis. Suppl. 1989:S52–S61. [Google Scholar]
  4. Bukrinskaya A.G., Vorkunova N.K., Pushkarskaya N.L. Vol. 60. 1982. Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine; pp. 61–66. (J. Gen. Virol.). [DOI] [PubMed] [Google Scholar]
  5. Charnet P., Labarca C., Leonard R.J., Vogelaar N.J., Czyzyk L., Gouin A., Davidson N., Lester H.A. An open-channel blocker interacts with adjacent turns of a-helices in the nicotinic acetylcholine receptor. Neuron. 1990;4:87–95. doi: 10.1016/0896-6273(90)90445-l. [DOI] [PubMed] [Google Scholar]
  6. Chou P.Y., Fasman G.D. Empirical predictions of protein conformation. Annu. Rev. Biochem. 1978;47:251–276. doi: 10.1146/annurev.bi.47.070178.001343. [DOI] [PubMed] [Google Scholar]
  7. Doms R.W., Helenius A. Quaternary structure of influenza virus haemagglutinin after acid treatment. J. Virol. 1986;60:833–839. doi: 10.1128/jvi.60.3.833-839.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eldefrawi A.T., Miller E.R., Murphy D.L., Eldefrawi M.E. [3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, anti psychotic opiate, antidepressant, antibiotic, antiviral and antiarrhythmic drug. Mol. Pharmacol. 1982;22:72–81. [PubMed] [Google Scholar]
  9. Hay A.I. The mechanism of action of amantadine and rimantadine against influenza viruses. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis III. Springer-Verlag; New York: 1989. pp. 561–567. [Google Scholar]
  10. Hay A.J., Wolstenholme A.J., Skehel J.J., Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 1985;4:3021–3024. doi: 10.1002/j.1460-2075.1985.tb04038.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hay A.J., Zambon M.C., Wolstenholme A.J., Skehel J.J., Smith M.H. Molecular basis of resistance of influenza A viruses to amantadine. J. Antimicrob. Chemother. 1986;18(Suppl. B):19–29. doi: 10.1093/jac/18.supplement_b.19. [DOI] [PubMed] [Google Scholar]
  12. Hiebert S.W., Patterson R.G., Lamb R.A. Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J. Virol. 1985;55:744–751. doi: 10.1128/jvi.55.3.744-751.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kato N., Eggers H.J. Inhibition of uncoating of fowl plague virus by 1-adamantanamine hydrochloride. Virology. 1969;37:632–641. doi: 10.1016/0042-6822(69)90281-5. [DOI] [PubMed] [Google Scholar]
  14. Klimkait T. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 1990;64:621–629. doi: 10.1128/jvi.64.2.621-629.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lamb R.A., Zebedee S.L., Richardson C.D. Influenza virus M2 protein is an integral membrane protein expressed on the infected cell surface. Cell. 1985;40:627–633. doi: 10.1016/0092-8674(85)90211-9. [DOI] [PubMed] [Google Scholar]
  16. Leonard R.J., Labarca C.G., Charnet P., Davidson N., Lester H.A. Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor. Science. 1988;242:1578–1581. doi: 10.1126/science.2462281. [DOI] [PubMed] [Google Scholar]
  17. Olmsted R.A., Collins P.L. The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J. Virol. 1989;63:2019–2029. doi: 10.1128/jvi.63.5.2019-2029.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ruigrok R.W.H., Hirst E.M.A., Hay A.J. The specific inhibition of influenza A virus maturation by amantadine-An electronmicroscopic examination. J. Gen. Virol. 1990 doi: 10.1099/0022-1317-72-1-191. in press. [DOI] [PubMed] [Google Scholar]
  19. Smith A.R., Boursnell M.E.G., Binns M.M., Brown T.D.K., Inglis S.C. Identification of a new membrane-associated polypeptide specified by the coronavirus infectious bronchitis virus. J. Gen. Virol. 1990;71:3–11. doi: 10.1099/0022-1317-71-1-3. [DOI] [PubMed] [Google Scholar]
  20. Sugrue R.J., Bahadur G., Zambon M.C., Hall-Smith M., Douglas A.R., Hay A.J. Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 1990;9:3469–3476. doi: 10.1002/j.1460-2075.1990.tb07555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sugrue R.J., Belshe R.B., Hay A.J. Palmitoylation of the influenza A virus M2 protein. Virology. 1990;179:51–56. doi: 10.1016/0042-6822(90)90272-s. [DOI] [PubMed] [Google Scholar]
  22. Terwilliger E.F., Cohen E.A., Lu Y., Sodroski J.G., Haseltine W.A. Vol. 86. 1989. Functional role of human immunodeficiency virus type 1 vpu; pp. 5163–5167. (Proc. Natl. Acad. Sci.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thornton J.M. Disulphide bridges in globular proteins. J. Mol. Biol. 1981;151:261–287. doi: 10.1016/0022-2836(81)90515-5. [DOI] [PubMed] [Google Scholar]
  24. Warnick J.E., Maleque M.A., Bakry N., Eldefrawi A.T., Albuquerque E.X. Structure-activity relationships of amantadine: I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane. Mol. Pharmacol. 1982;22:82–93. [PubMed] [Google Scholar]
  25. Williams M.A., Lamb R.A. Determination of the orientation of an integral membrane protein and sites of glycosylation by oligonucleotide-directed mutagenesis: Influenza B virus NB glycoprotein lacks a cleavable signal sequence and has an extracellular NH, -terminal region. Mol. Cell. Biol. 1986;6:4317–4328. doi: 10.1128/mcb.6.12.4317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zebedee S.L., Lamb R.A. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 1988;62:2762–2772. doi: 10.1128/jvi.62.8.2762-2772.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]